Literature DB >> 16472822

Mutational analysis of the catalytic domain of the murine Dnmt3a DNA-(cytosine C5)-methyltransferase.

Humaira Gowher1, Panida Loutchanwoot, Olga Vorobjeva, Vikas Handa, Renata Z Jurkowska, Tomasz P Jurkowski, Albert Jeltsch.   

Abstract

On the basis of amino acid sequence alignments and structural data of related enzymes, we have performed a mutational analysis of 14 amino acid residues in the catalytic domain of the murine Dnmt3a DNA-(cytosine C5)-methyltransferase. The target residues are located within the ten conserved amino acid sequence motifs characteristic for cytosine-C5 methyltransferases and in the putative DNA recognition domain of the enzyme (TRD). Mutant proteins were purified and tested for their catalytic properties and their abilities to bind DNA and AdoMet. We prepared a structural model of Dnmt3a to interpret our results. We demonstrate that Phe50 (motif I) and Glu74 (motif II) are important for AdoMet binding and catalysis. D96A (motif III) showed reduced AdoMet binding but increased activity under conditions of saturation with S-adenosyl-L-methionine (AdoMet), indicating that the contact of Asp96 to AdoMet is not required for catalysis. R130A (following motif IV), R241A and R246A (in the TRD), R292A, and R297A (both located in front of motif X) showed reduced DNA binding. R130A displayed a strong reduction in catalytic activity and a complete change in flanking sequence preferences, indicating that Arg130 has an important role in the DNA interaction of Dnmt3a. R292A also displayed reduced activity and changes in the flanking sequence preferences, indicating a potential role in DNA contacts farther away from the CG target site. N167A (motif VI) and R202A (motif VIII) have normal AdoMet and DNA binding but reduced catalytic activity. While Asn167 might contribute to the positioning of residues from motif VI, according to structural data Arg202 has a role in catalysis of cytosine-C5 methyltransferases. The R295A variant was catalytically inactive most likely because of destabilization of the hinge sub-domain of the protein.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16472822     DOI: 10.1016/j.jmb.2006.01.035

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  39 in total

1.  Mapping of protein-protein interaction sites by the 'absence of interference' approach.

Authors:  Arunkumar Dhayalan; Tomasz P Jurkowski; Heike Laser; Richard Reinhardt; Da Jia; Xiaodong Cheng; Albert Jeltsch
Journal:  J Mol Biol       Date:  2007-12-23       Impact factor: 5.469

2.  The R882H DNMT3A mutation associated with AML dominantly inhibits wild-type DNMT3A by blocking its ability to form active tetramers.

Authors:  David A Russler-Germain; David H Spencer; Margaret A Young; Tamara L Lamprecht; Christopher A Miller; Robert Fulton; Matthew R Meyer; Petra Erdmann-Gilmore; R Reid Townsend; Richard K Wilson; Timothy J Ley
Journal:  Cancer Cell       Date:  2014-03-20       Impact factor: 31.743

3.  Oligomerization and binding of the Dnmt3a DNA methyltransferase to parallel DNA molecules: heterochromatic localization and role of Dnmt3L.

Authors:  Renata Z Jurkowska; Arumugam Rajavelu; Nils Anspach; Claus Urbanke; Gytis Jankevicius; Sergey Ragozin; Wolfgang Nellen; Albert Jeltsch
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

Review 4.  Epigenetic regulators and their impact on therapy in acute myeloid leukemia.

Authors:  Friederike Pastore; Ross L Levine
Journal:  Haematologica       Date:  2016-03       Impact factor: 9.941

5.  Cooperative DNA binding and protein/DNA fiber formation increases the activity of the Dnmt3a DNA methyltransferase.

Authors:  Max Emperle; Arumugam Rajavelu; Richard Reinhardt; Renata Z Jurkowska; Albert Jeltsch
Journal:  J Biol Chem       Date:  2014-08-21       Impact factor: 5.157

6.  The Impact of DNA Methylation in Hematopoietic Malignancies.

Authors:  Maria Guillamot; Luisa Cimmino; Iannis Aifantis
Journal:  Trends Cancer       Date:  2016-02-01

Review 7.  The role of mutations in epigenetic regulators in myeloid malignancies.

Authors:  Alan H Shih; Omar Abdel-Wahab; Jay P Patel; Ross L Levine
Journal:  Nat Rev Cancer       Date:  2012-08-17       Impact factor: 60.716

Review 8.  Repeat-Induced Point Mutation and Other Genome Defense Mechanisms in Fungi.

Authors:  Eugene Gladyshev
Journal:  Microbiol Spectr       Date:  2017-07

9.  Structure of Dnmt3a bound to Dnmt3L suggests a model for de novo DNA methylation.

Authors:  Da Jia; Renata Z Jurkowska; Xing Zhang; Albert Jeltsch; Xiaodong Cheng
Journal:  Nature       Date:  2007-08-22       Impact factor: 49.962

10.  Human DNMT2 methylates tRNA(Asp) molecules using a DNA methyltransferase-like catalytic mechanism.

Authors:  Tomasz P Jurkowski; Madeleine Meusburger; Sameer Phalke; Mark Helm; Wolfgang Nellen; Gunter Reuter; Albert Jeltsch
Journal:  RNA       Date:  2008-06-20       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.